{"id":"NCT02342275","sponsor":"West China Hospital","briefTitle":"Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma","officialTitle":"Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2018-09","completion":"2018-09","firstPosted":"2015-01-19","resultsPosted":"2022-06-16","lastUpdate":"2022-06-16"},"enrollment":377,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Hemangioma"],"interventions":[{"type":"DRUG","name":"Propranolol","otherNames":["Oral propranolol"]},{"type":"DRUG","name":"Atenolol","otherNames":["Oral atenolol"]}],"arms":[{"label":"Propranolol","type":"ACTIVE_COMPARATOR"},{"label":"Atenolol","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the efficacy of orally administered propranolol versus atenolol in the treatment of potentially disfiguring or functionally threatening IHs.","primaryOutcome":{"measure":"The Primary Outcome Measure Was Any Response at 6 Months","timeFrame":"6 month","effectByArm":[{"arm":"Propranolol","deltaMin":178,"sd":null},{"arm":"Atenolol","deltaMin":173,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"}]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":1,"countries":["China"]},"refs":{"pmids":["25196392","24479731","24374526","24033364","24011909","21763565","33856430"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":190},"commonTop":["Diarrhea","Sleep disturbance","Bradycardia","Agitation","Cool extremities"]}}